StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.46+0.13 (+9.77%)

Close on Nov 20, 2026Market cap $22.07MP/E –Yield –

CervoMed net income

Net income is the profit left for shareholders after every expense, interest and tax.

CervoMed's net income for the twelve months ending Jun 30, 2026 was -$30.35M. For fiscal 2025 it was -$26.97M. The highest annual figure on record is -$1.36M in fiscal 2017.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$26.97M–
FY2024Dec 31, 2024-$16.29M–
FY2023Dec 31, 2023-$2.17M–
FY2022Dec 31, 2022-$5.80M–
FY2021Dec 31, 2021-$24.10M–
FY2020Dec 31, 2020-$14.19M–
FY2019Dec 31, 2019-$11.80M–
FY2018Dec 31, 2018-$18.37M–
FY2017Dec 31, 2017-$1.36M–
FY2016Dec 31, 2016-$18.04M–
FY2015Dec 31, 2015-$6.72M–
FY2014Dec 31, 2014-$14.35M–
FY2013Dec 31, 2013-$2.46M–
FY2012Dec 31, 2012-$6.87M–
FY2011Dec 31, 2011-$22.64M–
FY2010Dec 31, 2010-$8.41M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.57M–
Q1 FY2026Mar 31, 2026-$7.96M–
Q4 FY2025Dec 31, 2025-$8.09M–
Q3 FY2025Sep 30, 2025-$7.73M–
Q2 FY2025Jun 30, 2025-$6.26M–
Q1 FY2025Mar 31, 2025-$4.89M–
Q4 FY2024Dec 31, 2024-$6.71M–
Q3 FY2024Sep 30, 2024-$4.75M-321.1%
Q2 FY2024Jun 30, 2024-$2.32M–
Q1 FY2024Mar 31, 2024-$2.51M–
Q4 FY2023Dec 31, 2023-$2.36M–
Q3 FY2023Sep 30, 2023$2.15M–
Q2 FY2023Jun 30, 2023-$1.43M–
Q1 FY2023Mar 31, 2023-$534.34K–
Q4 FY2022Dec 31, 2022-$1.53M–
Q3 FY2022Sep 30, 2022-$882.62K–
Q2 FY2022Jun 30, 2022-$4.19M–
Q1 FY2022Mar 31, 2022-$4.53M–
Q4 FY2021Dec 31, 2021-$3.47M–
Q3 FY2021Sep 30, 2021-$12.20M–
Q2 FY2021Jun 30, 2021-$3.78M–
Q1 FY2021Mar 31, 2021-$4.64M–
Q4 FY2020Dec 31, 2020-$4.06M–
Q3 FY2020Sep 30, 2020-$4.44M–
Q2 FY2020Jun 30, 2020-$3.13M–
Q1 FY2020Mar 31, 2020-$2.56M–
Q4 FY2019Dec 31, 2019-$3.75M–
Q3 FY2019Sep 30, 2019-$2.80M–
Q2 FY2019Jun 30, 2019-$2.50M–
Q1 FY2019Mar 31, 2019-$2.75M–
Q4 FY2018Dec 31, 2018-$5.57M-411.3%
Q3 FY2018Sep 30, 2018-$6.72M-231.8%
Q2 FY2018Jun 30, 2018-$2.77M-113.6%
Q1 FY2018Mar 31, 2018-$3.31M–
Q4 FY2017Dec 31, 2017$1.79M–
Q3 FY2017Sep 30, 2017$5.10M–
Q2 FY2017Jun 30, 2017$20.39M–
Q1 FY2017Mar 31, 2017-$28.64M–
Q4 FY2016Dec 31, 2016-$2.57M–
Q3 FY2016Sep 30, 2016-$5.44M–

More CervoMed figures

See a number that looks wrong?